Valuation Nile Pharmaceuticals and Chemical Industries Company

Stocks

End-of-day quote Egyptian Exchange 28/10/2026			5-day change	1st Jan Change
254.50 ^EGP	+5.16%		-9.98%	+153.94%

30/09	EI- Nile Co. for Pharmaceuticals and Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2026	CI
21/05	EI- Nile Co. for Pharmaceuticals and Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026
Market Cap ¹	354.1	359	404.9	699.2	1,465	8,202
Change	-	1.4%	12.77%	72.69%	109.54%	459.75%
Enterprise Value (EV) ¹	287.9	385.2	596	1,240	2,433	9,739
Change	-	33.83%	54.7%	108.1%	96.15%	300.34%
P/E	5.5x	4x	3.4x	7.75x	11.7x	32x
PBR	0.95x	0.83x	0.85x	1.49x	1.97x	7.66x
PEG	-	0.1x	0.1x	-0.3x	-0.2x	1.4x
Capitalization / Revenue	0.47x	0.41x	0.4x	0.61x	1.14x	3.84x
EV / Revenue	0.38x	0.44x	0.59x	1.09x	1.89x	4.56x
EV / EBITDA	2.67x	2.76x	3.39x	7.97x	7.9x	16.2x
EV / EBIT	3.01x	3.07x	3.66x	8.64x	8.71x	18.2x
EV / FCF	5.53x	-6.04x	-4.67x	-5.34x	-4.75x	-15.3x
FCF Yield	18.1%	-16.6%	-21.4%	-18.7%	-21.1%	-6.52%
Dividend per Share ²	2	2.97	5	3.71	2	-
Rate of return	5.72%	8.38%	12.5%	5.37%	4.1%	-
EPS ²	6.363	8.856	11.77	8.911	4.191	5.127
Distribution rate	31.4%	33.5%	42.5%	41.6%	47.7%	-
Net sales ¹	755.5	876.8	1,005	1,143	1,290	2,134
EBITDA ¹	107.7	139.4	175.9	155.5	307.9	602
EBIT ¹	95.6	125.4	162.8	143.5	279.3	535.2
Net income ¹	64.42	89.67	119.2	90.23	125.7	256.4
Net Debt ¹	-66.22	26.21	191.1	540.9	967.4	1,537
Reference price ²	34.97	35.46	39.99	69.06	48.84	164.03
Nbr of stocks (in thousands)	10,125	10,125	10,125	10,125	30,000	50,000
Announcement Date	14/09/21	19/09/22	20/09/23	24/09/24	09/09/25	30/09/26

¹EGP in Million²EGP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NILE PHARMACEUTICALS AND CHEMICAL INDUSTRIES COMPANY	-	-	-	-	22Cr
ELI LILLY AND COMPANY	37.66x	13.18x	27.98x	0.53%	1,14300Cr
JOHNSON & JOHNSON	39.33x	6.61x	18.6x	1.99%	65TCr
ABBVIE INC.	37.45x	8.4x	17.37x	2.4%	51TCr
ROCHE HOLDING AG	21.46x	5.22x	12.98x	2.51%	38TCr
MERCK & CO., INC.	103.38x	5.8x	24.86x	2.4%	35TCr
NOVARTIS AG	21.99x	5.69x	13.69x	2.94%	29TCr
ASTRAZENECA PLC	22.31x	4.51x	12.87x	1.96%	26TCr
AMGEN INC.	28.42x	7.28x	13.03x	2.25%	24TCr
GILEAD SCIENCES, INC.	-45.78x	7.1x	27.53x	2.07%	20TCr
Average	29.58x	7.09x	18.77x	2.12%	40.28TCr
Weighted average by Cap.	35.27x	8.35x	20.48x	1.8%